Exacerbation Research (22)
22 papers in the Exacerbation topic, indexed by PF-Atlas from PubMed and global journals.
- Association Between Single Nucleotide Polymorphisms and Disease Susceptibility, Survival, and Acute Exacerbation in Idiopathic Pulmonary Fibrosis. · Respirology (Carlton, Vic.) · 2026
- Efficacy and safety of RApid PrednIsolone Dose reduction for acute exacerbation of Idiopathic Pulmonary Fibrosis : a study protocol for a randomised controlled trial. · BMJ open respiratory research · 2026
- Clinical Outcomes and Acute Exacerbation Incidence in Combined Pulmonary Fibrosis and Emphysema. · Respirology (Carlton, Vic.) · 2026
- Acute exacerbation in fibrotic interstitial lung disease: An International Working Group Report. · American journal of respiratory and critical care medicine · 2026
- Tocilizumab for the treatment of acute exacerbation of idiopathic pulmonary fibrosis: A matched case-control retrospective study. · Therapeutic advances in respiratory disease · 2026
- Nintedanib Treatment of Patients With Interstitial Lung Diseases: A Retrospective Study of Daily Clinical Practice. · In vivo (Athens, Greece) · 2026
- Postoperative acute exacerbations in patients with idiopathic pulmonary fibrosis undergoing lung cancer surgery. · Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG · 2026
- Outcomes of invasive mechanical ventilation in critically ill patients with interstitial lung disease: protocol for a systematic review and meta-analysis. · BMJ open · 2026
- Health care utilization and costs associated with acute exacerbation of fibrosing interstitial lung disease in the United States: A retrospective administrative claims database analysis. · Journal of managed care & specialty pharmacy · 2026
- Protocol for the INterstitial lung Disease EXacerbations Study: a retrospective multicentre cohort study. · BMJ open respiratory research · 2026
- A syndromic framework for progressive pulmonary fibrosis. · Respiratory research · 2026
- Acute Exacerbation of Interstitial Lung Disease: A Case Series and a Narrative Literature Review. · Advances in respiratory medicine · 2026
- Should nintedanib be continued after acute exacerbation of idiopathic pulmonary fibrosis? A retrospective observational study using a nationwide database in Japan. · Respiratory medicine and research · 2026
- Managing Acute Exacerbations in Idiopathic Pulmonary Fibrosis and Progressive Pulmonary Fibrosis in the Intensive Care Unit Setting. · Critical care nursing clinics of North America · 2025
- Evaluation of Factors Affecting Mortality in Patients with Idiopathic Pulmonary Fibrosis: A 10-Year Single-Center Experience. · Diagnostics (Basel, Switzerland) · 2025
- Acute Exacerbation of Interstitial Lung Disease: Early Diagnosis and Treatment. · Medicina (Kaunas, Lithuania) · 2025
- Combined pulmonary fibrosis and emphysema: a narrative review. · Frontiers in medicine · 2025
- Clinical relevance of microvascular endothelial dysfunction in idiopathic pulmonary fibrosis. · ERJ open research · 2025
- Risk stratification of acute exacerbations by autoantibodies in patients with idiopathic interstitial pneumonia. · Scientific reports · 2025
- Epidemiological and Clinical Evidence on the Association Between Wildfire PM2.5 and Pulmonary Health Outcomes. · Cureus · 2025
- Geriatric nutrition risk index as an indicator of acute exacerbation and mortality risk in patients with idiopathic pulmonary fibrosis. · BMC geriatrics · 2025
- Development of a Prediction Model for Acute Exacerbation in Idiopathic Pulmonary Fibrosis: A Study of the Korea IPF Cohort Registry. · Journal of Korean medical science · 2025
Medical disclaimer. Research listings are for information only and are not medical advice.